Solasia Pharma K.K Balance Sheet Health
Financial Health criteria checks 5/6
Solasia Pharma K.K has a total shareholder equity of ¥1.8B and total debt of ¥500.0M, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are ¥2.7B and ¥885.0M respectively.
Key information
27.4%
Debt to equity ratio
JP¥500.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥1.32b |
Equity | JP¥1.82b |
Total liabilities | JP¥885.00m |
Total assets | JP¥2.71b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4597's short term assets (¥1.5B) exceed its short term liabilities (¥837.0M).
Long Term Liabilities: 4597's short term assets (¥1.5B) exceed its long term liabilities (¥48.0M).
Debt to Equity History and Analysis
Debt Level: 4597 has more cash than its total debt.
Reducing Debt: 4597's debt to equity ratio has increased from 0% to 27.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4597 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4597 has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 7.8% each year.